PHILADELPHIA, July 30, 2020 /PRNewswire/ — Providence Treatment, an outpatient addiction treatment provider with three locations in the Greater Philadelphia area, has acquired Main Line Recovery, an outpatient facility in Haverford, Pennsylvania, offering comprehensive assessment for behavioral health concerns and psychotherapy for individuals, couples, families and groups. Main Line Recovery facility will officially operate under Providence Treatment’s name effective August

BayMark Health Services has recently acquired a Narcotic Addiction Treatment Agency (NATA), an Opioid Treatment Program (OTP) in Sun Valley, CA.  In business for over 35 years, the company provides medication-assisted treatment (MAT) in the San Fernando Valley area. The company’s focus is to provide comprehensive treatment for opioid addiction professionally without losing sight of the compassion component. NATA specializes in outpatient methadone maintenance and detoxificati

Hospice and home health provider Traditions Health, LLC has acquired Tomball, Texas-based Hospice with Grace, expanding the company’s footprint in the Houston region. Financial terms of the transaction were not disclosed. Traditions is a portfolio company of family-owned investment firm Dorilton Capital Advisors that operates in Texas, California and Arizona. The hospice provider has been on a growth trajectory during 2019 and into 2020. “I am extremely excited to extend our

BATON ROUGE, La., June 01, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ:AMED), a leading provider of home health, hospice and personal care, announced today that, through one of its wholly owned subsidiaries, it has closed on its acquisition of Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice” or “AseraCare”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Ark

LOUISVILLE, Ky.–(BUSINESS WIRE)–Kindred Healthcare, LLC (“Kindred” or the “Company”) today announced it has signed a definitive agreement with WellBridge Healthcare (“WellBridge”) to acquire two behavioral health hospitals, WellBridge Greater Dallas and WellBridge Fort Worth, in the Dallas-Fort Worth metropolitan area. WellBridge Greater Dallas and WellBridge Fort Worth provide a full continuum of inpatient and outpatient behavioral health services to senior and adult populat

NEW ORLEANS (PRWEB) May 15, 2020 AppleGate Recovery, a BayMark Health Services company, announced this week the acquisition of Medication Assisted Recovery Centers (MARC), an office-based opioid treatment (OBOT) program with two locations near New Orleans, LA. The clinics, situated in Metairie and Slidell, provide medication-assisted treatment (MAT) and recovery services in a physician’s office setting. AppleGate Recovery now operates 8 clinics serving the residents of Louisi

COVID-19 Short-term Impact on Healthcare* M&A Buyer Mindset *Home Health, Home Care and Hospice and Behavioral Health In response to questions from the media, buyers, and sellers, Mertz Taggart undertook a qualitative survey of industry buyers. There has been a wealth of conjecture and prognostication about the short- and long-term effects of the COVID-19 outbreak on healthcare in general and mergers and acquisitions in particular. Rather than guessing, we decided to talk to

The Resurgence of Private Duty Home Care M&A 2018 was a booming year for health care M&A activity. That’s especially true when it comes to private duty home care transactions, largely because services that improve functional mobility, maintain cognitive engagement, and address social determinants of health are being increasingly valued within the broader continuum of care. Of the home health, hospice and home care segments, the home health industry saw the greatest number of

Considering a Hospice Sale At Some Point? Get Your Documentation in Order Now For hospice organizations looking to sell, the market has never been hotter. That is, of course, if a seller has all of its clinical records and compliance documentation in order. Hospice deal volume increased substantially from 2017 to 2018, increasing from 28 deals in 2017 to nearly 40 last year, proprietary Mertz Taggart data shows. In many cases, these transactions have included double-digit EBI

Why Exit Does Not (and Should Not) Mean Retirement Many people assume that when the subject of “exit” comes up with a business owner, we are discussing the owner’s retirement. This is not always true, and assuming it is true creates problems for owners, their companies, and their families. Exit does not have to mean retirement. Separating exit and retirement (and approaching them differently) makes for better exit planning, a smoother transition for the company, and happier l

Three Trends Driving M&A in Home Health, Home Care and Hospice Mergers and acquisitions “M&A” have become a major strategy for health care companies seeking to succeed in a rapidly evolving marketplace, with payment systems rewarding value more than volume. That’s especially true when it comes to the home health, home care, and hospice industries, which have all seen record-breaking M&A action, along with skyrocketing valuations. Hospice, buoyed by higher margins, has been pa

Inside the Kindred Deal…and Why It Makes Sense As many of you have likely heard by now, on December 18, Humana announced an agreement to partner with private equity firms TPG Capital and Welsh, Carson, Anderson & Stowe (WCAS) to acquire Kindred Healthcare for $4.1 billion in a landmark transaction for the home health and hospice industry. Under the terms of the deal, TPG and WCAS will acquire 100% of Kindred’s long-term care facilities while partnering with Humana to acquire

Treatment Center Value Insights: It’s All About the Multiple (…Or Is It?) I get asked all the time…’what kind of multiple would my treatment center command?’ ‘Not So Fast’…There’s No Straight Answer. I would go as far as saying it’s irresponsible to give guidance simply in the form of a multiple without knowing the other half of the valuation equation – Adjusted EBITDA. The Adjusted EBITDA can be dramatically different depending on whether it is based on a trailing twelve-mon